156 related articles for article (PubMed ID: 29217453)
1. Tumor-Suppressing Effect of Silencing of Annexin A3 Expression in Breast Cancer.
Kim JY; Jung EJ; Park HJ; Lee JH; Song EJ; Kwag SJ; Park JH; Park T; Jeong SH; Jeong CY; Ju YT; Lee YJ; Hong SC
Clin Breast Cancer; 2018 Aug; 18(4):e713-e719. PubMed ID: 29217453
[TBL] [Abstract][Full Text] [Related]
2. Silencing of ANXA3 expression by RNA interference inhibits the proliferation and invasion of breast cancer cells.
Zhou T; Li Y; Yang L; Liu L; Ju Y; Li C
Oncol Rep; 2017 Jan; 37(1):388-398. PubMed ID: 27878264
[TBL] [Abstract][Full Text] [Related]
3. Annexin A3 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma.
Pan QZ; Pan K; Weng DS; Zhao JJ; Zhang XF; Wang DD; Lv L; Jiang SS; Zheng HX; Xia JC
Mol Carcinog; 2015 Aug; 54(8):598-607. PubMed ID: 24375474
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of annexin A3 inhibits tumor metastasis and decreases drug resistance in breast cancer.
Du R; Liu B; Zhou L; Wang D; He X; Xu X; Zhang L; Niu C; Liu S
Cell Death Dis; 2018 Jan; 9(2):126. PubMed ID: 29374148
[TBL] [Abstract][Full Text] [Related]
5. Annexin A3 is associated with a poor prognosis in breast cancer and participates in the modulation of apoptosis in vitro by affecting the Bcl-2/Bax balance.
Zeng C; Ke Z; Song Y; Yao Y; Hu X; Zhang M; Li H; Yin J
Exp Mol Pathol; 2013 Aug; 95(1):23-31. PubMed ID: 23631820
[TBL] [Abstract][Full Text] [Related]
6. The expression of ANXA3 and its relationship with the occurrence and development of breast cancer.
Zhou T; Liu S; Yang L; Ju Y; Li C
J BUON; 2018; 23(3):713-719. PubMed ID: 30003741
[TBL] [Abstract][Full Text] [Related]
7. The regulatory role of Annexin 3 in a nude mouse bearing a subcutaneous xenograft of MDA-MB-231 human breast carcinoma.
Li J; Zhou T; Liu L; Ju YC; Chen YT; Tan ZR; Wang J
Pathol Res Pract; 2018 Oct; 214(10):1719-1725. PubMed ID: 30236487
[TBL] [Abstract][Full Text] [Related]
8. Annexin A3 Knockdown Suppresses Lung Adenocarcinoma.
Liu YF; Liu QQ; Zhang YH; Qiu JH
Anal Cell Pathol (Amst); 2016; 2016():4131403. PubMed ID: 27995049
[TBL] [Abstract][Full Text] [Related]
9. Annexin A3 as a Prognostic Biomarker for Breast Cancer: A Retrospective Study.
Zhou T; Li Y; Yang L; Tang T; Zhang L; Shi J
Biomed Res Int; 2017; 2017():2603685. PubMed ID: 28497041
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of ANXA3 is an independent prognostic indicator in gastric cancer and its depletion suppresses cell proliferation and tumor growth.
Wang K; Li J
Oncotarget; 2016 Dec; 7(52):86972-86984. PubMed ID: 27894078
[TBL] [Abstract][Full Text] [Related]
11. Annexin A3 depletion overcomes resistance to oxaliplatin in colorectal cancer via the MAPK signaling pathway.
Xu R; Yin J; Zhang Y; Zhang S
J Cell Biochem; 2019 Sep; 120(9):14585-14593. PubMed ID: 30998268
[TBL] [Abstract][Full Text] [Related]
12. Impact of Annexin A3 expression in gastric cancer cells.
Yu SY; Li Y; Fan LQ; Zhao Q; Tan BB; Liu Y
Neoplasma; 2014; 61(3):257-64. PubMed ID: 24824926
[TBL] [Abstract][Full Text] [Related]
13. Microglial Annexin A3 promoted the development of melanoma via activation of hypoxia-inducible factor-1α/vascular endothelial growth factor signaling pathway.
Xu B; Zhang X; Gao Y; Song J; Shi B
J Clin Lab Anal; 2021 Feb; 35(2):e23622. PubMed ID: 33118214
[TBL] [Abstract][Full Text] [Related]
14. ANXA3, associated with YAP1 regulation, participates in the proliferation and chemoresistance of cervical cancer cells.
Huang J; Wei W; Kang F; Tan S; Li Y; Lu X; Wang N
Genes Genomics; 2023 Dec; 45(12):1575-1586. PubMed ID: 37843781
[TBL] [Abstract][Full Text] [Related]
15. Expression and significance of Annexin A3 in the osteosarcoma cell lines HOS and U2OS.
Zeng X; Wang S; Gui P; Wu H; Li Z
Mol Med Rep; 2019 Sep; 20(3):2583-2590. PubMed ID: 31524248
[TBL] [Abstract][Full Text] [Related]
16. LncRNA EBLN3P Facilitates Osteosarcoma Metastasis by Enhancing Annexin A3 mRNA Stability and Recruiting HuR.
Wang S; Zeng X; Gui P; Xu S; Li Z; Chen D
Ann Surg Oncol; 2023 Dec; 30(13):8690-8703. PubMed ID: 37598115
[TBL] [Abstract][Full Text] [Related]
17. Annexin A3 is a mammary marker and a potential neoplastic breast cell therapeutic target.
Zeidan B; Jackson TR; Larkin SE; Cutress RI; Coulton GR; Ashton-Key M; Murray N; Packham G; Gorgoulis V; Garbis SD; Townsend PA
Oncotarget; 2015 Aug; 6(25):21421-7. PubMed ID: 26093083
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of neoadjuvant chemotherapy and Annexin A3 expression in breast cancer.
Zhu S; Li Y; Wang Y; Cao J; Li X; Wang J; Wang X
J BUON; 2019; 24(2):522-528. PubMed ID: 31128000
[TBL] [Abstract][Full Text] [Related]
19. Annexin A3 as a potential target for immunotherapy of liver cancer stem-like cells.
Pan QZ; Pan K; Wang QJ; Weng DS; Zhao JJ; Zheng HX; Zhang XF; Jiang SS; Lv L; Tang Y; Li YQ; He J; Liu Q; Chen CL; Zhang HX; Xia JC
Stem Cells; 2015 Feb; 33(2):354-66. PubMed ID: 25267273
[TBL] [Abstract][Full Text] [Related]
20. [Effect of down-regulation of Oct4 gene on biological characteristics of MDA-MB-231 breast cancer stem cells].
Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):251-7. PubMed ID: 26462888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
